Get started
WEST PHARMAWW

WEST PHARMA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

1WST chart


Full chart

1WST upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.95 B‬ EUR
Dividend yield (indicated)
0.37%
Price to earnings Ratio (TTM)
35.80
Basic EPS (TTM)
5.95 EUR
Net income (FY)
‪475.94 M‬ EUR
Revenue (FY)
‪2.79 B‬ EUR
Shares float
‪71.39 M‬
Beta (1Y)
0.59

Employees


Employees (FY)
‪10.6 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪263.61 K‬ EUR
Net income / Employee (1Y)
‪44.90 K‬ EUR

About West Pharmaceutical Services, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Eric Mark Green
Website
westpharma.com
Headquarters
Exton
Founded
1923
FIGI
BBG01TNY7ZF4
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1WST news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of 1WST is 194.85 EUR — it has decreased by −0.97% in the past 24 hours. Watch WEST PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange WEST PHARMA stocks are traded under the ticker 1WST.
1WST stock has risen by 4.28% compared to the previous week, the month change is a 0.10% rise, over the last year WEST PHARMA has showed a 4.62% increase.
We've gathered analysts' opinions on WEST PHARMA future price: according to them, 1WST price has a max estimate of 285.45 EUR and a min estimate of 215.19 EUR. Watch 1WST chart and read a more detailed WEST PHARMA stock forecast: see what analysts think of WEST PHARMA and suggest that you do with its stocks.
1WST reached its all-time high on May 13, 2025 with the price of 194.65 EUR, and its all-time low was 180.65 EUR and was reached on May 23, 2025. View more price dynamics on 1WST chart.
See other stocks reaching their highest and lowest prices.
1WST stock is 0.98% volatile and has beta coefficient of 0.59. Track WEST PHARMA stock price on the chart and check out the list of the most volatile stocks — is WEST PHARMA there?
Today WEST PHARMA has the market capitalization of ‪13.89 B‬, it has increased by 2.31% over the last week.
Yes, you can track WEST PHARMA financials in yearly and quarterly reports right on TradingView.
WEST PHARMA is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
1WST earnings for the last quarter are 1.34 EUR per share, whereas the estimation was 1.13 EUR resulting in a 18.13% surprise. The estimated earnings for the next quarter are 1.31 EUR per share. See more details about WEST PHARMA earnings.
WEST PHARMA revenue for the last quarter amounts to ‪645.19 M‬ EUR, despite the estimated figure of ‪633.81 M‬ EUR. In the next quarter, revenue is expected to reach ‪626.95 M‬ EUR.
1WST net income for the last quarter is ‪83.01 M‬ EUR, while the quarter before that showed ‪125.67 M‬ EUR of net income which accounts for −33.95% change. Track more WEST PHARMA financial stats to get the full picture.
Yes, 1WST dividends are paid quarterly. The last dividend per share was 0.19 EUR. As of today, Dividend Yield (TTM)% is 0.37%. Tracking WEST PHARMA dividends might help you take more informed decisions.
WEST PHARMA dividend yield was 0.25% in 2024, and payout ratio reached 12.27%. The year before the numbers were 0.22% and 9.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 13, 2025, the company has ‪10.6 K‬ employees. See our rating of the largest employees — is WEST PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WEST PHARMA EBITDA is ‪700.10 M‬ EUR, and current EBITDA margin is 25.93%. See more stats in WEST PHARMA financial statements.
Like other stocks, 1WST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WEST PHARMA stock right from TradingView charts — choose your broker and connect to your account.